Zobrazeno 1 - 10
of 176
pro vyhledávání: '"I, Londono"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nidhi Goel, Rebecca C. Arend, McKenzie E. Foxall, Brandon M. Roane, Angelina I. Londono, Charles A. Leath, Jaclyn A. Wall, Jhalak Dholakia, Warner K. Huh
Publikováno v:
Gynecologic Oncology. 163:85-92
Both incidence and mortality of uterine cancer are on the rise and mortality is higher for African American women. The aim of our study was to evaluate how Next Generation Sequencing (NGS) may facilitate identification of and intervention for treatme
Autor:
Angelina I. Londono, Nidhi Goel, Rebecca C. Arend, Ashwini A. Katre, Dewey Brooke, Tyler R. McCaw, Troy D. Randall, Haller J. Smith
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 709-717 (2021)
Cancer Medicine
Cancer Medicine
Objective Patients with epithelial ovarian cancer (EOC) typically present with late‐stage disease, posing a significant challenge to treatment. Although taxane and platinum‐based chemotherapy plus surgical debulking are initially effective, EOC i
Autor:
Lyse A. Norian, Selene Meza-Perez, Angelina I. Londono, Rebecca C. Arend, Carly Bess Scalise, Jaclyn A. Wall, William J. Turbitt, Ashwini A. Katre, Troy D. Randall
Publikováno v:
Gynecol Oncol
Objective Immune checkpoint blockade (ICB) therapy shows limited efficacy in ovarian cancers due to the “cold” immune phenotype surrounding these tumors. Previous studies have shown that in ovarian cancer Wnt/β-catenin pathway activation contrib
Autor:
Troy D. Randall, Angelina I. Londono, Sara J. Cooper, Whitney N. Goldsberry, Rebecca C. Arend, Lyse A. Norian, Nidhi Goel, Brandon M. Roane, Ashwini A. Katre, Bryan T. Mott, Selene Meza-Perez, Michael J. Birrer, Jaclyn A. Wall
Publikováno v:
Cancers, Vol 12, Iss 3, p 766 (2020)
Cancers
Volume 12
Issue 3
Cancers
Volume 12
Issue 3
In ovarian cancer, upregulation of the Wnt/&beta
&ndash
catenin pathway leads to chemoresistance and correlates with T cell exclusion from the tumor microenvironment (TME). Our objectives were to validate these findings in an independent co
&ndash
catenin pathway leads to chemoresistance and correlates with T cell exclusion from the tumor microenvironment (TME). Our objectives were to validate these findings in an independent co
Autor:
Lyse A. Norian, J. Michael Straughn, Selene Meza-Perez, Troy D. Randall, Donald J. Buchsbaum, Eddy S. Yang, Haller J. Smith, Andres Forero, Tyler R. McCaw, Ashwini A. Katre, Angelina I. Londono, Rebecca C. Arend
Publikováno v:
Cancer. 124:4657-4666
Background Ovarian cancer is poorly immunogenic; however, increased major histocompatibility complex class II (MHCII) expression correlates with improved immune response and prolonged survival in patients with ovarian cancer. The authors previously d
Autor:
Zachary C. Dobbin, Eddy S. Yang, Angelina I. Londono, J. Michael Straughn, Ronald D. Alvarez, Jacob M. Estes, David K. Crossman, Lea Novak, Ashwini A. Katre, Rebecca C. Arend, Allison M. Montgomery, Sara J. Cooper, Kerri S. Bevis, Alba Martinez, Charles A. Leath, Warner K. Huh, Charles N. Landen, Haller J. Smith
Publikováno v:
Molecular Cancer Research. 16:813-824
While high-grade serous ovarian carcinoma (HGSOC) is the most common histologic subtype of ovarian cancer, significant tumor heterogeneity exists. In addition, chemotherapy induces changes in gene expression and alters the mutational profile. To eval
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Lipid Research, Vol 31, Iss 11, Pp 1937-1946 (1990)
Despite the evidence that the human small intestine produces two separate species of apoB mRNA encoding for B-100 and B-48, there is a paucity of data concerning the expression of the latter form in this organ. Using a high resolution immunogold appr
Externí odkaz:
https://doaj.org/article/44b1a8f2a2694329a1127e31b601e1c9
Publikováno v:
Gynecologic Oncology. 158:e9-e10